Therapy of ANCA-associated systemic vasculitides: current approaches


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modern therapeutic approaches to treatment of ANCA-associated systemic vasculitides and algoritms of treatment choice are presented. Controlled clinical trials in patients with ANCA-associated systemic vasculitides are discussed. Role of target biological therapy of systemic vasculitides is reviewed.

References

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies